CIK 0001393434
- Large accelerated filer
OCULAR THERAPEUTIX, INC
Sign in to watch- Ticker
- OCUL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 781-357-4000
- Business address
- 14 CROSBY DRIVE, 3RD FLOOR, BEDFORD, MA, 01730
- Former names
- I-THERAPEUTIX INC
- 4 Grant or award Chief Legal Officer acquired 64,900 shares (grant or award)
- 4 Grant or award Chief Commercial Officer acquired 64,900 shares (grant or award)
- 4 Grant or award Chief Strategy Officer acquired 64,900 shares (grant or award)
- 4 Grant or award Chief Development Officer acquired 79,112 shares (grant or award)
- 4 Grant or award Chief Business Officer acquired 79,112 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 79,112 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 79,112 shares (grant or award)
- 4 Grant or award See Remarks acquired 79,112 shares (grant or award)
- 4 Planned sale Chief Strategy Officer sold 1,878 shares at $12.04 ($22,611)
- 4 Planned sale See Remarks sold 19,530 shares at $12.04 ($235,141)
- 4 Planned sale Chief Development Officer sold 3,007 shares at $12.02 ($36,144)
- 4 Planned sale Chief Scientific Officer sold 3,469 shares at $12.04 ($41,767)
- 4 Planned sale Chief Business Officer sold 25,865 shares at $10.74 ($277,790)
- 4 Planned sale Chief Legal Officer sold 11,132 shares at $12.34 ($137,369)
- 4 Planned sale Chief Development Officer sold 9,653 shares at $11.03 ($106,473)
- 4 Planned sale Chief Scientific Officer sold 10,502 shares at $11.04 ($115,942)
- 4 Gift See Remarks gave 49,754 shares (gift)
- 4 Open-market sale See Remarks sold 1,066 shares at $12.43 ($13,250)
- 4 Planned sale Chief Development Officer sold 3,011 shares at $12.04 ($36,252)
- 4 Planned sale Chief Strategy Officer sold 1,885 shares at $12.04 ($22,695)
Page 3 of 18 · 354 filings